Global Insulin Storage Devices Market

Global Insulin Storage Devices Market Size, Share, Growth Analysis, By Product(Insulated Kits, Insulin Cooling Wallets), By Patient(Type 1 Diabetes, Type 2 Diabetes) - Industry Forecast 2024-2031


Report ID: SQMIG35A2495 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 64 | Figures: 75

Global Insulin Storage Devices Market Competitive Landscape

The competitive landscape of the global insulin storage devices market is characterized by a blend of established healthcare companies, innovative startups, and technological pioneers. Key players in the market include prominent medical device manufacturers, pharmaceutical companies, and specialized firms dedicated to diabetes management solutions. These industry leaders leverage their extensive expertise, distribution networks, and research capabilities to offer a diverse range of insulin storage devices that cater to the evolving needs of patients.

Innovation remains a driving force, as companies continuously strive to enhance the usability, convenience, and technological sophistication of their products. This includes the development of smart insulin storage devices with features like temperature monitoring, mobile app integration, and data connectivity. Furthermore, collaborations between pharmaceutical giants and device manufacturers are fostering cross-industry synergies, resulting in advanced solutions that address the unique requirements of diabetes patients.

Insulin Storage Devices Market Top Player’s Company Profiles

  • ReadyCare, LLC (USA)
  • DISONCARE (China)
  • Medicool (China)
  • Tawa Outdoor (China)
  • Cooluli (France)
  • Arkray, Inc. (Japan)
  • Zhengzhou Olive Electronic Technology Co., Ltd. (China)
  • Zhengzhou Defrigus Electric Device Co., Ltd. (China)
  • COOL Sarl-FR (France)
  • AfriMedix (South Africa)
  • Insulet Corporation (USA)
  • BD (USA)
  • Medtronic (Ireland)
  • Novo Nordisk (Denmark)
  • Sanofi (France)
  • Roche (Switzerland)
  • Ypsomed (Switzerland)
  • Terumo (Japan)
  • Abbot Diabetes Care (USA)
  • Nipro Corporation (Japan)

Insulin Storage Devices Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Insulin Storage Devices Market size was valued at USD 870 Million in 2022 and is poised to grow from USD 941.34 Million in 2023 to USD 1768.34 Million by 2031, at a CAGR of 8.20% during the forecast period (2024-2031). 

The competitive landscape of the global insulin storage devices market is characterized by a blend of established healthcare companies, innovative startups, and technological pioneers. Key players in the market include prominent medical device manufacturers, pharmaceutical companies, and specialized firms dedicated to diabetes management solutions. These industry leaders leverage their extensive expertise, distribution networks, and research capabilities to offer a diverse range of insulin storage devices that cater to the evolving needs of patients. 'ReadyCare, LLC (USA)', 'DISONCARE (China)', 'Medicool (China)', 'Tawa Outdoor (China)', 'Cooluli (France)', 'Arkray, Inc. (Japan)', 'Zhengzhou Olive Electronic Technology Co., Ltd. (China)', 'Zhengzhou Defrigus Electric Device Co., Ltd. (China)', 'COOL Sarl-FR (France)', 'AfriMedix (South Africa)', 'Insulet Corporation (USA)', 'BD (USA)', 'Medtronic (Ireland)', 'Novo Nordisk (Denmark)', 'Sanofi (France)', 'Roche (Switzerland)', 'Ypsomed (Switzerland)', 'Terumo (Japan)', 'Abbot Diabetes Care (USA)', 'Nipro Corporation (Japan)'

The increasing global incidence of diabetes, particularly type 1 and type 2, is a primary driver for insulin storage devices as these devices are essential for effective insulin management.

Smart and Connected Devices: The integration of IoT technology is leading to the development of smart insulin storage devices that offer features like temperature monitoring, reminders, and connectivity with smartphones.

Notably, North America commands a prominent position in the market due to its substantial patient base and favorable reimbursement policies. The region secured a substantial market share of 45.67% in 2022. This is underpinned by Canada's noteworthy contribution, where over 3 million individuals are grappling with diabetes, with the prevalence rate growing by approximately 3.3% annually, accounting for the elderly population. Furthermore, escalating healthcare expenditures by consumers in North America are propelling market growth.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Insulin Storage Devices Market

Product ID: SQMIG35A2495

$5,300
BUY NOW GET FREE SAMPLE